by Eric Christianson | Jan 11, 2026 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
In this blog post, I’ll share my top 5 gout pharmacotherapy pearls. This can often show up in practice as well as on those challenging board exams! Allopurinol Doesn’t Treat Flares Allopurinol reduces the production of uric acid. Because of this mechanism,...
by Eric Christianson | Jan 7, 2026 | Polypharmacy Cases And The Prescribing Cascade
Mr. H is a 78-year-old male presenting to a primary care clinic for a routine medication review. In this scenario, we want to identify deprescribing targets. His past medical history includes hypertension, heart failure with preserved ejection fraction (HFpEF),...
by Eric Christianson | Jan 4, 2026 | Drug Interaction Case Studies and Education For Pharmacists
In this case scenario, we outline the Paxlovid alprazolam interaction. A 42-year-old woman with a long-standing history of severe generalized anxiety disorder, managed with alprazolam 1 mg orally twice daily for several years, presented to the emergency department...
by Eric Christianson | Dec 31, 2025 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Pimavanserin is a unique antipsychotic with a very specific niche in clinical practice. It is most commonly used for Parkinson’s disease psychosis, and its pharmacology, benefits, and risks are frequently tested and clinically misunderstood. In this blog post,...
by Eric Christianson | Dec 28, 2025 | Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
Alpha-blockers are not first-line agents for many conditions, but they are often tested on exams and highly relevant in practice—especially in urology, hypertension, and acute care settings. Understanding their nuances can help prevent serious adverse effects and...
